Sanofi

News

Goofy lama pulling face. Funny llama animal sticking tongue out

Can llama antibodies beat COVID-19? Belgium's ExeVir raises ...

Belgium’s ExeVir Bio is to accelerate development of a new treatment for COVID-19 based on llama antibodies, after a 23 million euro ($27 million) financing round.

News

UK places order for 60m doses of Sanofi/GSK’s COVID-19 vacci...

The UK government has signed its fourth coronavirus vaccine deal, snapping up 60 million doses of an experimental shot being developed by Sanofi and GlaxoSmithKline.

News

Sanofi set to spin off API business late next year - report

Sanofi is to begin preparations in autumn to spin off its active ingredients business and is lining up a potential stock market launch by 2022, according to a press report.

News

Kymera Therapeutics begins potential $2bn R&D deal with Sano...

US biotech Kymera Therapeutics has begun a strategic collaboration with Sanofi to develop and market several drugs tackling immune-inflammatory disease, which could be worth up to $2 billio

News

LEO eyeing 2021 US launch for eczema drug tralokinumab

LEO Pharma is gearing up to launch its eczema drug tralokinumab next year after submitting a filing to the FDA, as it bids to take on Sanofi’s class rival Dupixent.

News

Kiadis Pharma and Sanofi to unlock power of natural killer c...

Sanofi has struck an exclusive rights deal with Dutch biotech Kiadis focused on combining modified natural killer cells with the French pharma’s blood cancer antibody Sarcl

Can llama antibodies beat COVID-19? Belgium's ExeVir raises ...

UK places order for 60m doses of Sanofi/GSK’s COVID-19 vacci...

Sanofi set to spin off API business late next year - report

Kymera Therapeutics begins potential $2bn R&D deal with Sano...

LEO eyeing 2021 US launch for eczema drug tralokinumab

Kiadis Pharma and Sanofi to unlock power of natural killer c...

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

Sanofi

Editor's Picks